All News
Aging in RA: "(RA) is due to a poorly functioning immune system which increases a patients risk of CVD, infection, and cancer. The aging immune system additionally affects this process. We must consider this clinically, we must protect our aging patients without over… https://t.co/TlHyTxPMNc https://t.co/JBVg4uqn6A
Links:
Dr. Rachel Tate uptoTate ( View Tweet)
#RNL2024 @RheumNow
As we age, we gain not just wisdom, but also "Inflammaging"
Immune system changes in our inflammatory cells lead to:
- Poor vaccine response
- High risks for infections
- High risk for CVD
- High risk for autoimmunity https://t.co/golMAPR0ZI
Eric Dein ericdeinmd ( View Tweet)
Check out the #RNL2024 command center! This hardworking team is bringing you the virtual conference stream!
@RheumNow https://t.co/dsA1949Lrj
Dr. Rachel Tate uptoTate ( View Tweet)
Dr Weber would add low dose #colchicine in pts who are at very high CV risk. Be careful with pts who have CKD #RNL2024 @rheumnow https://t.co/k00vqiQlI5
TheDaoIndex KDAO2011 ( View Tweet)
Useful resource on dietary guidance in RA from @ACRheum focusing on a MD-like diet #RNL2024 @RheumNow https://t.co/QplaQ1caxv.
Dr. Antoni Chan synovialjoints ( View Tweet)
An amazing handout showing Art of communicating risk and benefit with our patients to promote shared decision making.
Will defiantly start using it in my clinic.
Hani El Gabalawy.
#RNL2024
@RheumNow https://t.co/Gl7uUCQbnv
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Vit d and omega 3 reduces incidence of RA.
Hani El Gabalawy.
#RNL2024
@RheumNow https://t.co/BGGbLvMhhT
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Good number of ACPA positive patients reverts to ACPA negative in 5 years.
Hani El Gabalawy.
#RNL2024
@RheumNow https://t.co/yLxO0ulsam
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Dr. Kavanaugh: "Role of alcohol on inflammation? It's part of the Mediterranean diet!"
Dr. Guma:"The data is mixed; polyphenols may be beneficial; alcohol in limited quantities was allowed in studies"
Dr. Weber:" Be careful w/EtOH in pts w/palpitations"
#RNL2024 @rheumnow
TheDaoIndex KDAO2011 ( View Tweet)
Do you use the ASA24?
Dr. Gabalawy asked Dr. Guma about this index at the #RNL2024. These indices don't quite encompass all aspects of the ACR recommended Mediterranean diet, for example, but could be useful in developing better assessments for patients and their diet.… https://t.co/v4Fu43u7et https://t.co/CTV2IaJ1xW
Links:
Dr. Rachel Tate uptoTate ( View Tweet)
Panel discussion online and in person on #rheumatoidarthritis #RNL2024 Dr. Weber discusses with Dr. Guma, Dr. Gabalawy and @rheumnow ways to assess CV risk in patients by looking at family history, inflammation, comorbidities, imaging studies https://t.co/yM58kvr7CR
TheDaoIndex KDAO2011 ( View Tweet)
Happening Now! RheumNowLive @RheumNow
Stil time to register and join; only $105 for fellows!
Clinically focused & high yield; check it out! https://t.co/ADTEbsJrxP
Mike Putman EBRheum ( View Tweet)
How do you communicate risk/benefit to patients? @RADoctor's recent publication highlighted by Dr. H. Gabalawy at #RNL2024 @RheumNow
1. Increase awareness
2. Include numbers for context
3. Make it easy for patients to understand those numbers
4. Use absolute risks
5. Avoid 1 in… https://t.co/DqmgD2j5Wp https://t.co/v6CQAX9YRr
Links:
Dr. Rachel Tate uptoTate ( View Tweet)
Managing patients with clinically suspect arthritis (CSA), <20% of ACPA positive patients without arthralgia develop RA in 5 years, Hani El Gabalwy #RNL2024 @RheumNow https://t.co/RKaDsozhXl
Dr. Antoni Chan synovialjoints ( View Tweet)
Per this study: 40% of pts had RA at 5 years and 40% were seronegative at 5 years. (See red line box) Interesting finding from Dr. H. Gabalawy #RNL2024 @RheumNow https://t.co/m5zJkDO2bk
Dr. Rachel Tate uptoTate ( View Tweet)
“Less than 20% of low +CCP patients who are asymptomatic will develop RA over 5 years” – Dr. Gabalawy recommends lifestyle changes (STOP smoking, Mediterranean diet, exercise) ; a substantial proportion will revert to ACPA neg state #RNL2024 @RheumNow https://t.co/yyHwVZWOf0
Links:
TheDaoIndex KDAO2011 ( View Tweet)
Why should we care about preclinical RA? Goal: to treat once and stop the trajectory of the disease. – Dr. Gabalawy #RNL2024 @rheumnow https://t.co/afbpvrZV8v
TheDaoIndex KDAO2011 ( View Tweet)
<20% of anti-CCP+ pts without arthralgia with develop RA in 5 years!
Dr. H. Gabalawy
#RNL2024 @RheumNow https://t.co/OXe7EWfCmc
Dr. Rachel Tate uptoTate ( View Tweet)
#RNL2024 @RheumNow
TREAT-EARLIER - MTX for Clinically Suspect Arthralgias
No overall diff vs PBO
High risk pts had benefit, but not sustained at 2 yrs
But sustained reduction in HAQ & MRI inflammation
- Signs for hope? Overall, prevention studies have been disappointing https://t.co/DtBlGaw0Lf
Links:
Eric Dein ericdeinmd ( View Tweet)
Rheums are "all over the map" but tend to skew conservatively when treating pre-clinical RA.
Dr. H Gabalawy discusses the results of a case-driven polling question at #RNL2024 @RheumNow.
Be sure to register at https://t.co/DXQ0KCelIh to hear his, and other, lectures to weigh… https://t.co/Yo3ChNwNIO https://t.co/wD3AMUDNr9
Links:
Dr. Rachel Tate uptoTate ( View Tweet)